EUVIMEDEUVIMED entdecken
Crossref

In silico study of active anticancer peptides from soybean ( Glycine max (L.) Merr.) as therapeutic agents in hepatocellular carcinoma

Wahyu Aristyaning Putri, Didik Huswo Utomo, Teuku Muhammad Dzaki Syarief, Cahyo Wulandari, Rusyda Auliya, Yekti Asih Purwestri

Journal of Herbmed Pharmacology · 01.07.2026 · 15 (3) · 324-332

DOI: 10.34172/jhp.52979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Herbmed Pharmacology, online erschienen am 01.07.2026. Verfasst von Wahyu Aristyaning Putri und 5 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Soybean-derived peptides have emerged as promising therapeutic agents in oncology due to their bioactivity, low toxicity, and biocompatibility. This study aimed to conduct a comparative analysis to assess whether soybean-derived anticancer peptides could serve as therapeutic agents in hepatocellular carcinoma (HCC).

Methods

The peptide structures were predicted using UCSF ChimeraX, while the preparation of target proteins and peptides was performed using BIOVIA Discovery Studio Visualizer. The interactions between the peptides and the SALL4-NuRD, VEGF, and GPC3 proteins were analyzed through molecular docking studies.

Results

Docking results revealed that the peptide WMLPSYSPY exhibited superior binding affinity (-237.813) compared to other peptides. Alanine scanning assays demonstrated that residues Tyr6 and Tyr9 played crucial roles in peptide interactions with SALL4-NuRD and VEGF, while Trp1 and Tyr6 were crucial for peptide interaction with GPC3.

Conclusion

Predictive characteristics of the WMLPSYSPY peptide suggest its potential as a therapeutic agent for HCC, albeit with low stability and uptake. Further in vitro and in vivo studies are warranted, alongside structural modifications to enhance its pharmacological properties.

Zitieren

APA

Putri, W. A., Utomo, D. H., Syarief, T. M. D., Wulandari, C., Auliya, R., & Purwestri, Y. A. (2026). In silico study of active anticancer peptides from soybean ( Glycine max (L.) Merr.) as therapeutic agents in hepatocellular carcinoma. Journal of Herbmed Pharmacology, 15(3), 324-332. https://doi.org/10.34172/jhp.52979

Vancouver

Putri WA, Utomo DH, Syarief TMD, Wulandari C, Auliya R, Purwestri YA. In silico study of active anticancer peptides from soybean ( Glycine max (L.) Merr.) as therapeutic agents in hepatocellular carcinoma. Journal of Herbmed Pharmacology. 2026;15(3):324-332. doi:10.34172/jhp.52979

BibTeX
@article{Putri2026,
  author = {Putri, Wahyu Aristyaning and Utomo, Didik Huswo and Syarief, Teuku Muhammad Dzaki and Wulandari, Cahyo and Auliya, Rusyda and Purwestri, Yekti Asih},
  title = {In silico study of active anticancer peptides from soybean ( Glycine max (L.) Merr.) as therapeutic agents in hepatocellular carcinoma},
  journal = {Journal of Herbmed Pharmacology},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {324--332},
  doi = {10.34172/jhp.52979}
}
Kostenlos starten →